DEP® ADCs exploit the unique potential of Starpharma's DEP® technology to provide enhanced characteristics to ADCs i
New deal strengthens Congenica’s presence in India
Investment in response to increased demand for North American-based chemistry services
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
Bringing next-gen cannabinoid therapeutics to cancer patients
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Subscribe To Our Newsletter & Stay Updated
